Northstrive completes phase II of AI drug development program by northstrive | Sep 4, 2024 | StreetInsider
The Potential of Shareholder Activism: A Retrospective on Braeden Lichti’s Most Recent Campaign by northstrive | Mar 2, 2024 | USA Today
